| 1 |
24740684 | The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study. | 2015 May |
1 |
| 2 |
25492374 | Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients. | 2015 Nov |
1 |
| 3 |
25060604 | Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers. | 2014 Dec |
2 |
| 4 |
21241070 | Clinical pharmacokinetics of metformin. | 2011 Feb |
2 |
| 5 |
21270793 | Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants. | 2011 Mar |
1 |
| 6 |
19898263 | Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response. | 2010 Jan |
3 |
| 7 |
19336679 | Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study. | 2009 Jun |
2 |
| 8 |
19381165 | Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus. | 2009 Aug |
2 |